Combining a rhesus cytomegalovirus/SIV vaccine with a neutralizing antibody to protect against SIV challenges in rhesus macaques.
Saved in:
| Title: | Combining a rhesus cytomegalovirus/SIV vaccine with a neutralizing antibody to protect against SIV challenges in rhesus macaques. |
|---|---|
| Authors: | Coppola J; Department of Immunology and Microbiology, Scripps Consortium for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, IAVI Neutralizing Antibody Center, La Jolla, CA, United States., Parren M; Department of Immunology and Microbiology, Scripps Consortium for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, IAVI Neutralizing Antibody Center, La Jolla, CA, United States., Bastidas R; Department of Immunology and Microbiology, Scripps Consortium for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, IAVI Neutralizing Antibody Center, La Jolla, CA, United States., Saye K; Department of Immunology and Microbiology, Scripps Consortium for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, IAVI Neutralizing Antibody Center, La Jolla, CA, United States., Malvin J; Department of Immunology and Microbiology, Scripps Consortium for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, IAVI Neutralizing Antibody Center, La Jolla, CA, United States., Jardine JG; Department of Immunology and Microbiology, Scripps Consortium for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, IAVI Neutralizing Antibody Center, La Jolla, CA, United States., Gilbride RM; Vaccine & Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR, United States., Ojha S; Vaccine & Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR, United States., Feltham S; Vaccine & Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR, United States., Morrow D; Vaccine & Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR, United States., Barber-Axthelm A; Vaccine & Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR, United States., Bochart R; Vaccine & Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR, United States., Fast R; AIDS and Cancer Virus Program, Frederick National Laboratory, Leidos Biomedical Research, Inc., Frederick, MD, United States., Oswald K; AIDS and Cancer Virus Program, Frederick National Laboratory, Leidos Biomedical Research, Inc., Frederick, MD, United States., Shoemaker R; AIDS and Cancer Virus Program, Frederick National Laboratory, Leidos Biomedical Research, Inc., Frederick, MD, United States., Lifson JD; AIDS and Cancer Virus Program, Frederick National Laboratory, Leidos Biomedical Research, Inc., Frederick, MD, United States., Picker LJ; Vaccine & Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR, United States., Burton DR; Department of Immunology and Microbiology, Scripps Consortium for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, IAVI Neutralizing Antibody Center, La Jolla, CA, United States., Hansen SG; Vaccine & Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR, United States. |
| Source: | Frontiers in microbiology [Front Microbiol] 2025 Jun 02; Vol. 16, pp. 1592647. Date of Electronic Publication: 2025 Jun 02 (Print Publication: 2025). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Research Foundation Country of Publication: Switzerland NLM ID: 101548977 Publication Model: eCollection Cited Medium: Print ISSN: 1664-302X (Print) Linking ISSN: 1664302X NLM ISO Abbreviation: Front Microbiol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 40529575 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Combining a rhesus cytomegalovirus/SIV vaccine with a neutralizing antibody to protect against SIV challenges in rhesus macaques. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Coppola+J%22">Coppola J</searchLink>; Department of Immunology and Microbiology, Scripps Consortium for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, IAVI Neutralizing Antibody Center, La Jolla, CA, United States.<br /><searchLink fieldCode="AU" term="%22Parren+M%22">Parren M</searchLink>; Department of Immunology and Microbiology, Scripps Consortium for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, IAVI Neutralizing Antibody Center, La Jolla, CA, United States.<br /><searchLink fieldCode="AU" term="%22Bastidas+R%22">Bastidas R</searchLink>; Department of Immunology and Microbiology, Scripps Consortium for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, IAVI Neutralizing Antibody Center, La Jolla, CA, United States.<br /><searchLink fieldCode="AU" term="%22Saye+K%22">Saye K</searchLink>; Department of Immunology and Microbiology, Scripps Consortium for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, IAVI Neutralizing Antibody Center, La Jolla, CA, United States.<br /><searchLink fieldCode="AU" term="%22Malvin+J%22">Malvin J</searchLink>; Department of Immunology and Microbiology, Scripps Consortium for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, IAVI Neutralizing Antibody Center, La Jolla, CA, United States.<br /><searchLink fieldCode="AU" term="%22Jardine+JG%22">Jardine JG</searchLink>; Department of Immunology and Microbiology, Scripps Consortium for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, IAVI Neutralizing Antibody Center, La Jolla, CA, United States.<br /><searchLink fieldCode="AU" term="%22Gilbride+RM%22">Gilbride RM</searchLink>; Vaccine & Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR, United States.<br /><searchLink fieldCode="AU" term="%22Ojha+S%22">Ojha S</searchLink>; Vaccine & Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR, United States.<br /><searchLink fieldCode="AU" term="%22Feltham+S%22">Feltham S</searchLink>; Vaccine & Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR, United States.<br /><searchLink fieldCode="AU" term="%22Morrow+D%22">Morrow D</searchLink>; Vaccine & Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR, United States.<br /><searchLink fieldCode="AU" term="%22Barber-Axthelm+A%22">Barber-Axthelm A</searchLink>; Vaccine & Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR, United States.<br /><searchLink fieldCode="AU" term="%22Bochart+R%22">Bochart R</searchLink>; Vaccine & Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR, United States.<br /><searchLink fieldCode="AU" term="%22Fast+R%22">Fast R</searchLink>; AIDS and Cancer Virus Program, Frederick National Laboratory, Leidos Biomedical Research, Inc., Frederick, MD, United States.<br /><searchLink fieldCode="AU" term="%22Oswald+K%22">Oswald K</searchLink>; AIDS and Cancer Virus Program, Frederick National Laboratory, Leidos Biomedical Research, Inc., Frederick, MD, United States.<br /><searchLink fieldCode="AU" term="%22Shoemaker+R%22">Shoemaker R</searchLink>; AIDS and Cancer Virus Program, Frederick National Laboratory, Leidos Biomedical Research, Inc., Frederick, MD, United States.<br /><searchLink fieldCode="AU" term="%22Lifson+JD%22">Lifson JD</searchLink>; AIDS and Cancer Virus Program, Frederick National Laboratory, Leidos Biomedical Research, Inc., Frederick, MD, United States.<br /><searchLink fieldCode="AU" term="%22Picker+LJ%22">Picker LJ</searchLink>; Vaccine & Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR, United States.<br /><searchLink fieldCode="AU" term="%22Burton+DR%22">Burton DR</searchLink>; Department of Immunology and Microbiology, Scripps Consortium for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, IAVI Neutralizing Antibody Center, La Jolla, CA, United States.<br /><searchLink fieldCode="AU" term="%22Hansen+SG%22">Hansen SG</searchLink>; Vaccine & Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR, United States. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101548977%22">Frontiers in microbiology</searchLink> [Front Microbiol] 2025 Jun 02; Vol. 16, pp. 1592647. <i>Date of Electronic Publication: </i>2025 Jun 02 (<i>Print Publication: </i>2025). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation%22">Frontiers Research Foundation </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101548977 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>1664-302X (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%221664302X%22">1664302X </searchLink><i>NLM ISO Abbreviation: </i>Front Microbiol <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40529575 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.3389/fmicb.2025.1592647 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1592647 Titles: – TitleFull: Combining a rhesus cytomegalovirus/SIV vaccine with a neutralizing antibody to protect against SIV challenges in rhesus macaques. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Coppola J – PersonEntity: Name: NameFull: Parren M – PersonEntity: Name: NameFull: Bastidas R – PersonEntity: Name: NameFull: Saye K – PersonEntity: Name: NameFull: Malvin J – PersonEntity: Name: NameFull: Jardine JG – PersonEntity: Name: NameFull: Gilbride RM – PersonEntity: Name: NameFull: Ojha S – PersonEntity: Name: NameFull: Feltham S – PersonEntity: Name: NameFull: Morrow D – PersonEntity: Name: NameFull: Barber-Axthelm A – PersonEntity: Name: NameFull: Bochart R – PersonEntity: Name: NameFull: Fast R – PersonEntity: Name: NameFull: Oswald K – PersonEntity: Name: NameFull: Shoemaker R – PersonEntity: Name: NameFull: Lifson JD – PersonEntity: Name: NameFull: Picker LJ – PersonEntity: Name: NameFull: Burton DR – PersonEntity: Name: NameFull: Hansen SG IsPartOfRelationships: – BibEntity: Dates: – D: 02 M: 06 Text: 2025 Jun 02 Type: published Y: 2025 Identifiers: – Type: issn-print Value: 1664-302X Numbering: – Type: volume Value: 16 Titles: – TitleFull: Frontiers in microbiology Type: main |
| ResultId | 1 |